CN1176670C - 一种动物活性蛋白液及其应用 - Google Patents
一种动物活性蛋白液及其应用 Download PDFInfo
- Publication number
- CN1176670C CN1176670C CNB011419733A CN01141973A CN1176670C CN 1176670 C CN1176670 C CN 1176670C CN B011419733 A CNB011419733 A CN B011419733A CN 01141973 A CN01141973 A CN 01141973A CN 1176670 C CN1176670 C CN 1176670C
- Authority
- CN
- China
- Prior art keywords
- liquid
- active protein
- protein liquid
- active
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 55
- 235000021120 animal protein Nutrition 0.000 title claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 62
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000012153 distilled water Substances 0.000 claims abstract description 9
- 239000006228 supernatant Substances 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 235000018102 proteins Nutrition 0.000 claims description 55
- 241000522620 Scorpio Species 0.000 claims description 24
- 239000009490 scorpio Substances 0.000 claims description 24
- 241001312741 Gekko swinhonis Species 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 239000012467 final product Substances 0.000 claims description 7
- 239000000645 desinfectant Substances 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 5
- 230000008014 freezing Effects 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 241000411851 herbal medicine Species 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000009806 pulsatillae Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- -1 mixing Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 150000001413 amino acids Chemical class 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 206010020772 Hypertension Diseases 0.000 abstract description 2
- 241000239226 Scorpiones Species 0.000 abstract description 2
- 208000006011 Stroke Diseases 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 208000001749 optic atrophy Diseases 0.000 abstract description 2
- 239000000047 product Substances 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
动物蛋白 | 疾 病 | 治愈率,% | 有效率,% |
蝎子 | 风湿、类风湿30人 | 67 | 95 |
脑血栓后遗症20人 | 60 | 97 | |
壁虎 | 外伤 50人 | 98 | |
烧伤 10人 | 78.4-82.5% |
氨基酸 | mg/100mg样品 | 氨基酸 | mg/100mg样品 |
天门冬氨酸 | 0.54 | 亮氨酸 | 0.32 |
苏氨酸 | 0.21 | 酪氨酸 | 0.07 |
丝氨酸 | 0.23 | 苯丙氨酸 | 0.15 |
谷氨酸 | 0.41 | 赖氨酸 | 0.38 |
甘氨酸 | 0.19 | 氨 | 0.28 |
丙氨酸 | 0.15 | 组氨酸 | 0.25 |
缬氨酸 | 0.21 | 精氨酸 | 0.30 |
蛋氨酸 | 0.02 | 脯氨酸 | 0.07 |
异亮氨酸 | 0.18 | 总和 | 3.96 |
元素 | 分析结果,mg/kg | 元素 | 分析结果,mg/kg |
钾 | 343 | 铁 | 痕量 |
钠 | 0.29% | 铜 | 50 |
钙 | 166 | 锌 | 28 |
镁 | 43 | 硒 | 0.13 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011419733A CN1176670C (zh) | 2001-09-26 | 2001-09-26 | 一种动物活性蛋白液及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011419733A CN1176670C (zh) | 2001-09-26 | 2001-09-26 | 一种动物活性蛋白液及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1348771A CN1348771A (zh) | 2002-05-15 |
CN1176670C true CN1176670C (zh) | 2004-11-24 |
Family
ID=4676526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011419733A Expired - Fee Related CN1176670C (zh) | 2001-09-26 | 2001-09-26 | 一种动物活性蛋白液及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1176670C (zh) |
-
2001
- 2001-09-26 CN CNB011419733A patent/CN1176670C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1348771A (zh) | 2002-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI516280B (zh) | 紅藜萃取物用於製備促進膠原蛋白生成及抗皮膚老化之組合物之用途 | |
CN100512808C (zh) | 促进创面修复愈合的复方氨基酸外用制剂及制法和其应用 | |
RU2736055C1 (ru) | Композиция для улучшения внутреннего кровообращения и замедления старения, а также способ ее применения | |
CN108210878A (zh) | 补肾生精的虫草雪莲多糖复合物 | |
CN106362125A (zh) | 一种保健足贴及其使用方法 | |
KR100838113B1 (ko) | 식용금분이 함유된 상황버섯 재배방법 및 그 상황버섯 | |
CN1416825A (zh) | 活性地龙液及其制备方法 | |
JPH03503530A (ja) | ヒト腫瘍治療薬およびその製造方法 | |
WO2010043073A1 (zh) | 一种胶原多肽及其制备方法和应用 | |
CN1176670C (zh) | 一种动物活性蛋白液及其应用 | |
CN108187032A (zh) | 虫草胶原蛋白肽片 | |
CN104523756A (zh) | 一种蜂毒渗透剂及其制备方法、制剂与应用 | |
CN108148715A (zh) | 虫草多糖酒 | |
KR101713115B1 (ko) | 발효 오신채 추출물을 함유하는 화장료 조성물 | |
CN106491568A (zh) | 一种治疗皮肤外伤及感染的海洋生物喷膜及其制备方法 | |
CN104255954B (zh) | 一种黄蜀葵复方基础籽油及其制备方法和应用 | |
CN113040177A (zh) | 一种降解农作物农药残留的植物发酵提取物及其制备方法 | |
CN108420960B (zh) | 一种中药组合物及其制备方法 | |
RU2452242C1 (ru) | Способ получения биологически активной пищевой добавки | |
CN112043730A (zh) | 一种防治动物疫病的中药生物制剂 | |
CN102389074B (zh) | 含有多种氨基酸的地龙液及其制备方法 | |
CN104906132A (zh) | 一种防治羔羊口炎的膏药制剂 | |
WO2020037853A1 (zh) | 一种促进微循环、提高人体机能的组合物及其制法 | |
CN115778982B (zh) | 一种防治珍珠贝才女虫病的方法、药剂及其制备方法 | |
KR20190098336A (ko) | 불개미 효소분해 추출물을 유효성분으로 함유하는 전립성 비대증 또는 배뇨장애 개선용 약침의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LIU ZHANGQIN Effective date: 20050520 Owner name: ZHANG DONGYU Free format text: FORMER OWNER: BEIJING JINWEIYING BIOLOGICAL SCIENCE +. TECHNOLOGY CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20050520 Address after: 102600, Beijing, Daxing District Huang Village, Jinhua District, 3 floor, unit 7, Room 202 Co-patentee after: Liu Changqin Patentee after: Zhang Dongyu Address before: 102600 Beijing City, Daxing District Huangcun a third lane No. 17 Patentee before: Beijing Jinweiying Biological Science &. Technology Co., Ltd. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041124 Termination date: 20120926 |